KRRO is trading 5.1% down at $13.01 in pre-market, giving back part of its sharp gains from a strong multi-day rally between June 18 and June 22.
- The move appears to be normal volatility and profit-taking in the speculative small-cap biotech following its recent surge, as there are no fresh company-specific headlines, filings, or analyst calls this morning.
- The downward move comes despite a broadly firmer overall market environment.